semaglutide similar drugs Diabetes advocacy group discourages use of compounded GLP-1 FDA cracks down on weight-loss

Conditions like hypertension, prediabetes, or cardiovascular risks are often linked to excess weight

During this appointment, a healthcare professional will assess your eligibility for GLP-1 injections and discuss a tailored treatment plan to help you achieve your weight loss goals

ION STUDY LIFTS THE LID ON PLANT-BASED ALTERNATIVES OUR NEXT IN-PERSON OPEN EVENT IS HAPPENING ON 1 AUG 2026

OSA risk was assessed during the follow-up period using Cox regression

Oral GLP-1 medications reduce some barriers associated with injectable administration particularly convenience and needle aversion and may broaden uptake among patients who previously declined injectable therapy